Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial-Reference-Cited by-同舟云学术

Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial

Published:2016-04 Issue: Volume:209 Page:310-316
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Abdul-Rahim Azmil H.,MacIsaac Rachael L.,Jhund Pardeep S.,Petrie Mark C.,Lees Kennedy R.,McMurray John J.V.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure;Dei Cas;JACC Heart Fail,2015

2. Concomitant diabetes mellitus and heart failure;Dei Cas;Curr Probl Cardiol,2015

3. Diabetes, left ventricular systolic dysfunction, and chronic heart failure;MacDonald;Eur Heart J,2008

4. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure;Suskin;Eur Heart J,2000

5. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) programme;MacDonald;Eur Heart J,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis;Internal and Emergency Medicine;2024-08-22

2. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy;Frontiers in Endocrinology;2024-07-30

3. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;European Heart Journal;2023-08-25

4. BIOAVAILABILITY PROBLEMS OF PHYTOSTEROLS: A SYSTEMATIC REVIEW;International Journal of Applied Pharmaceutics;2022-11-07

5. Personalized Treatment of Heart Failure with Reduced Ejection Fraction: Ivabradine, Nitrate/Hydralazine, and Digoxin – A Systematic Review and Meta-Analysis;ABC Heart Fail Cardiomyop;2022